Moderna Q2 2024 GAAP EPS $(3.33) Beats $(3.36) Estimate, Sales $241.000M Beat $132.183M Estimate
Portfolio Pulse from Benzinga Newsdesk
Moderna reported its Q2 2024 financial results, with a GAAP EPS of $(3.33), beating the estimate of $(3.36). Sales were $241 million, surpassing the expected $132.183 million.
August 01, 2024 | 10:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Moderna's Q2 2024 GAAP EPS of $(3.33) beat the estimate of $(3.36), and sales of $241 million surpassed the expected $132.183 million.
Moderna's better-than-expected GAAP EPS and significantly higher sales indicate strong financial performance, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100